Virax Biolabs Group Limited Ordinary Shares (VRAX)

Virax Biolabs Group Limited Ordinary Shares (VRAX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.8M; returns 1 day -1.2%, 1 week -15.9%, 1 year -91.7%.

Virax Biolabs Group Limited (VRAX) is a biotechnology company concentrating on the development and commercialization of diagnostic technologies for immune responses to viral diseases and post-acute infection syndromes (PAIS).

Groups VRAX belongs to

• Healthcare
• Recent Reverse Splits
• United Kingdom Companies
• Biotechnology
• Clinical Stage
• Health Diagnostics and Imaging
• Infectious Diseases
• Post-Acute Care
• Life Sciences
• Healthcare Technology
• COVID-19

VRAX financial model: income statement, cash flow and balance sheet